XML 50 R6.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 3 Months Ended 10 Months Ended 12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2021
Dec. 31, 2022
Cash Flows from Operating Activities:        
Net income (loss) $ 1,499,978 $ (352,885) $ (1,100,581) $ 274,559
Adjustments to reconcile net income (loss) to net cash used in operating activities:        
General and administrative expenses paid by Sponsor in exchange for issuance of Class B ordinary shares     25,000 0
Income from investments held in Trust Account (2,797,302) (6,781) (12,561) (2,936,654)
Changes in operating assets and liabilities:        
Prepaid expenses 159,375 169,110 (1,121,860) 839,360
Accounts payable 53,874 33,009 87,097 200,431
Accrued expenses 766,454 83,902 142,704 1,396,991
Net cash used in operating activities (317,621) (73,645) (1,980,201) (225,313)
Cash Flows from Investing Activities:        
Cash deposited in Trust Account     (275,000,000) 0
Net cash used in investing activities     (275,000,000) 0
Cash Flows from Financing Activities:        
Repayment of note payable to related party     (108,892) 0
Proceeds from note payable to related party     108,892 0
Proceeds received from private placement     9,070,000 0
Proceeds received from initial public offering, gross     275,000,000 0
Offering costs paid     (6,351,813) (70,000)
Net cash provided by financing activities     277,718,187 (70,000)
Net change in cash (317,621) (73,645) 737,986 (295,313)
Cash - beginning of the period 442,673 737,986 0 737,986
Cash - end of the period 125,052 664,341 737,986 442,673
Supplemental disclosure of noncash activities:        
Offering costs included in accrued expenses     70,000 0
Deferred underwriting commissions in connection with the initial public offering     9,625,000 0
Extinguishment of deferred underwriting commissions allocated to Public Shares $ 3,609,375 $ 0 $ 0 $ 6,015,625